Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

sections

Your RPS 

Welsh Pharmacy Board meeting: 24 June 2020

At the latest Royal Pharmaceutical Society Welsh Pharmacy Board meeting, discussions revolved around board elections, inclusion and diversity, and key work undertaken in Wales.

Suzanne Scott Thomas Welsh Board Chair

Welsh Pharmacy Board chair, Suzanne Scott-Thomas

The Royal Pharmaceutical Society (RPS) Welsh Pharmacy Board (WPB) held its summer meeting via Zoom on 24 June 2020. In attendance at the meeting were Elen Jones, RPS director for Wales; Iwan Hughes, RPS Wales policy and public affairs executive; Jonathan Lloyd Jones, RPS Wales policy and engagement lead; Karen Hodson, RPS Wales practice and policy lead; Gino Martini, RPS chief scientist; Amandeep Doll, RPS inclusion and diversity co-ordinator; and Annamarie McGregor, RPS Local lead.

Apologies were received from board member Paul Harris.

Welsh Pharmacy Board elections

Elen Jones reminded the board that owing to the cancellation of the 2020 National Pharmacy Board elections, those members whose tenure was due to end this year would be asked if they would continue in place for another year. Board members to whom this applied were board chair Suzanne Scott-Thomas, and board members Paul Harris, Richard Evans and Rob Davies. It was noted that all four had agreed to continue until 2021. It was further noted that if those candidates are re-elected in 2021, they will serve for a further two years rather than three to take this arrangement into account.

It was also noted that Scott-Thomas was one year into a two-year tenure as board chair. Minutes of the meeting record that Scott-Thomas said she was “mindful not to impose another year on the WPB at this stage, particularly given that she would need to stand down next year”. The board gave its support for Scott-Thomas to continue in place, with no objections.

Director’s report

Jones noted that during the pandemic the RPS had been working as a ‘One RPS’ team, and highlighted some key work that had been undertaken with stakeholders in Wales. This included writing to Vaughan Gething, Welsh cabinet minister for health and social services, urging more support for the sector; and to Jane Hutt, Welsh government chief whip, to highlight issues affecting pharmacy staff from black, Asian and minority ethnic communities, including risks related to COVID-19. Amongst other activities, Jones and Scott-Thomas had presented oral evidence to the Health and Social Care Select Committee on COVID-19, followed up by written evidence.

Inclusion and Diversity report

Doll updated the board on the RPS’s inclusion and diversity work, with the board welcoming the five-year strategy report that was published on 22 June 2020. It was noted that RPS members who had attended an engagement workshop in Wales, which informed the strategy, had expressed great enthusiasm and support for the work.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20208153

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.